PPII Stock Overview

Coenzyme-A Inc. formulates and manufactures nutraceutical supplements, and skin and hair care products in the United States and internationally. More details

PPII fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($111)

Shares are highly illiquid

Latest financial reports are more than a year old

My Notes

Capture your thoughts, links and company narrative

Coenzyme-A Inc. Competitors

LifeQuest World

OTCPK:LQWC

US$957.6k

Nevis Brands

OTCPK:NEVI.F

US$2.1m

Cyanotech

OTCPK:CYAN

US$2.9m

Shineco

NasdaqCM:SISI

US$3.1m

Price History & Performance

Summary of share price highs, lows and changes for Coenzyme-A
Historical stock prices
Current Share Price	US$0.0002
52 Week High	US$0.0002
52 Week Low	US$0.0001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-99.97%
5 Year Change	-99.71%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	PPII	US Personal Products	US Market
7D	0%	-0.8%	-2.1%
1Y	n/a	-25.9%	21.3%

Return vs Industry: Insufficient data to determine how PPII performed against the US Personal Products industry.

Return vs Market: Insufficient data to determine how PPII performed against the US Market.

Price Volatility

Is PPII's price volatile compared to industry and market?
PPII volatility
PPII Average Weekly Movement	n/a
Personal Products Industry Average Movement	8.2%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: PPII has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PPII's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1998	n/a	Nickoloaus Skouras	n/a

Coenzyme-A Inc. formulates and manufactures nutraceutical supplements, and skin and hair care products in the United States and internationally. It offers energy drinks and skin rejuvinating serums, as well as fat management, skin treatment, fatty acid and cholesterol metabolism, and skin rejuvenating products, as well as nutritional formulas for the support of bone, joint, ligament, cartilage, and connective tissue functions. The company also provides sports-specific, women’s, and men’s formulas, as well as wellness, energy, and body sculpting products.

Coenzyme-A Inc. Fundamentals Summary

How do Coenzyme-A's earnings and revenue compare to its market cap?
PPII fundamental statistics
Market cap	US$111.00
Earnings (TTM)	-US$4.60m
Revenue (TTM)	US$345.65k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is PPII overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PPII income statement (TTM)
Revenue	US$345.65k
Cost of Revenue	US$117.09k
Gross Profit	US$228.56k
Other Expenses	US$4.83m
Earnings	-US$4.60m

Last Reported Earnings

Jun 30, 2010

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PPII perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/02/04 03:11
End of Day Share Price	2023/11/07 00:00
Earnings	2010/06/30
Annual Earnings	2009/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Coenzyme-A Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution